STERIS plc Net Income
| STE Stock | USD 243.81 20.46 7.74% |
As of the 5th of February, STERIS Plc has the risk adjusted performance of 0.0359, and Coefficient Of Variation of 2483.14. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STERIS plc, as well as the relationship between them. Please validate STERIS plc information ratio, as well as the relationship between the potential upside and kurtosis to decide if STERIS Plc is priced adequately, providing market reflects its prevalent price of 243.81 per share. Given that STERIS plc has jensen alpha of 0.0314, we advise you to double-check STERIS plc's current market performance to make sure the company can sustain itself at some point in the future.
STERIS Plc Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.7035 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 708.5 M | 743.9 M | |
| Net Income Applicable To Common Shares | 706.8 M | 742.2 M | |
| Net Income From Continuing Ops | 703.3 M | 738.5 M | |
| Net Income Per Share | 5.61 | 5.89 | |
| Net Income Per E B T | 0.89 | 0.85 |
STERIS | Net Income | Build AI portfolio with STERIS Stock |
Analyzing STERIS Plc's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing STERIS Plc's current valuation and future prospects.
Latest STERIS Plc's Net Income Growth Pattern
Below is the plot of the Net Income of STERIS plc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in STERIS plc financial statement analysis. It represents the amount of money remaining after all of STERIS plc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is STERIS Plc's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STERIS Plc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 616.07 M | 10 Years Trend |
|
Net Income |
| Timeline |
STERIS Net Income Regression Statistics
| Arithmetic Mean | 292,745,009 | |
| Geometric Mean | 189,601,674 | |
| Coefficient Of Variation | 75.90 | |
| Mean Deviation | 176,681,305 | |
| Median | 243,888,000 | |
| Standard Deviation | 222,207,003 | |
| Sample Variance | 49376T | |
| Range | 739.7M | |
| R-Value | 0.83 | |
| Mean Square Error | 16570T | |
| R-Squared | 0.69 | |
| Significance | 0.000041 | |
| Slope | 36,429,679 | |
| Total Sum of Squares | 790015.2T |
STERIS Net Income History
Other Fundumenentals of STERIS plc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
STERIS Plc Net Income component correlations
STERIS Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for STERIS Plc is extremely important. It helps to project a fair market value of STERIS Stock properly, considering its historical fundamentals such as Net Income. Since STERIS Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of STERIS Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of STERIS Plc's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could STERIS diversify its offerings? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STERIS Plc data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.286 | Earnings Share 7.17 | Revenue Per Share | Quarterly Revenue Growth 0.099 | Return On Assets |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, STERIS Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
STERIS Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to STERIS Plc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of STERIS Plc.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in STERIS Plc on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding STERIS plc or generate 0.0% return on investment in STERIS Plc over 90 days. STERIS Plc is related to or competes with DexCom, Insulet, Zimmer Biomet, Koninklijke Philips, Smith Nephew, Waters, and West Pharmaceutical. STERIS plc provides infection prevention and other procedural products and services worldwide More
STERIS Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure STERIS Plc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess STERIS plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.87 | |||
| Information Ratio | 0.0143 | |||
| Maximum Drawdown | 10.91 | |||
| Value At Risk | (2.45) | |||
| Potential Upside | 1.91 |
STERIS Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for STERIS Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as STERIS Plc's standard deviation. In reality, there are many statistical measures that can use STERIS Plc historical prices to predict the future STERIS Plc's volatility.| Risk Adjusted Performance | 0.0359 | |||
| Jensen Alpha | 0.0314 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0133 | |||
| Treynor Ratio | 0.0736 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of STERIS Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
STERIS Plc February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0359 | |||
| Market Risk Adjusted Performance | 0.0836 | |||
| Mean Deviation | 1.07 | |||
| Semi Deviation | 1.79 | |||
| Downside Deviation | 1.87 | |||
| Coefficient Of Variation | 2483.14 | |||
| Standard Deviation | 1.74 | |||
| Variance | 3.02 | |||
| Information Ratio | 0.0143 | |||
| Jensen Alpha | 0.0314 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0133 | |||
| Treynor Ratio | 0.0736 | |||
| Maximum Drawdown | 10.91 | |||
| Value At Risk | (2.45) | |||
| Potential Upside | 1.91 | |||
| Downside Variance | 3.51 | |||
| Semi Variance | 3.22 | |||
| Expected Short fall | (1.10) | |||
| Skewness | (0.64) | |||
| Kurtosis | 8.85 |
STERIS plc Backtested Returns
STERIS plc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0736, which indicates the firm had a -0.0736 % return per unit of volatility over the last 3 months. STERIS plc exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate STERIS Plc's coefficient of variation of 2483.14, and Risk Adjusted Performance of 0.0359 to confirm the risk estimate we provide. The entity has a beta of 0.82, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, STERIS Plc's returns are expected to increase less than the market. However, during the bear market, the loss of holding STERIS Plc is expected to be smaller as well. At this point, STERIS plc has a negative expected return of -0.11%. Please make sure to validate STERIS Plc's potential upside, and the relationship between the total risk alpha and kurtosis , to decide if STERIS plc performance from the past will be repeated at future time.
Auto-correlation | -0.13 |
Insignificant reverse predictability
STERIS plc has insignificant reverse predictability. Overlapping area represents the amount of predictability between STERIS Plc time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of STERIS plc price movement. The serial correlation of -0.13 indicates that less than 13.0% of current STERIS Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 24.65 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
STERIS Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, STERIS plc reported net income of 616.07 M. This is 80.52% higher than that of the Health Care Equipment & Supplies sector and 158.73% higher than that of the Health Care industry. The net income for all United States stocks is 7.9% lower than that of the firm.
STERIS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STERIS Plc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STERIS Plc could also be used in its relative valuation, which is a method of valuing STERIS Plc by comparing valuation metrics of similar companies.STERIS Plc is currently under evaluation in net income category among its peers.
STERIS Plc ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, STERIS Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to STERIS Plc's managers, analysts, and investors.Environmental | Governance | Social |
STERIS Plc Institutional Holders
Institutional Holdings refers to the ownership stake in STERIS Plc that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of STERIS Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing STERIS Plc's value.| Shares | Hhg Plc | 2025-06-30 | 1.5 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.4 M | Mitsubishi Ufj Asset Management Co.,ltd | 2025-06-30 | 1.3 M | Franklin Resources Inc | 2025-06-30 | 1.3 M | Sustainable Growth Advisers, Lp | 2025-06-30 | 1.2 M | Amvescap Plc. | 2025-06-30 | 1.2 M | Norges Bank | 2025-06-30 | 1.2 M | Principal Financial Group Inc | 2025-06-30 | 1.2 M | Pictet Asset Manangement Sa | 2025-06-30 | 1.1 M | Vanguard Group Inc | 2025-06-30 | 12.2 M | Blackrock Inc | 2025-06-30 | 8.6 M |
STERIS Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0643 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 27.41 B | ||||
| Shares Outstanding | 98.15 M | ||||
| Shares Owned By Insiders | 0.30 % | ||||
| Shares Owned By Institutions | 97.86 % | ||||
| Number Of Shares Shorted | 1.27 M | ||||
| Price To Earning | 36.93 X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 4.21 X | ||||
| Revenue | 5.46 B | ||||
| Gross Profit | 2.54 B | ||||
| EBITDA | 1.36 B | ||||
| Net Income | 616.07 M | ||||
| Cash And Equivalents | 171.7 M | ||||
| Cash Per Share | 3.16 X | ||||
| Total Debt | 2.2 B | ||||
| Debt To Equity | 0.49 % | ||||
| Current Ratio | 2.03 X | ||||
| Book Value Per Share | 67.17 X | ||||
| Cash Flow From Operations | 1.15 B | ||||
| Short Ratio | 2.48 X | ||||
| Earnings Per Share | 7.17 X | ||||
| Price To Earnings To Growth | 1.81 X | ||||
| Target Price | 281.63 | ||||
| Number Of Employees | 17.79 K | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 24.01 B | ||||
| Total Asset | 10.15 B | ||||
| Retained Earnings | 2.48 B | ||||
| Working Capital | 978.59 M | ||||
| Current Asset | 972.52 M | ||||
| Current Liabilities | 400.61 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.96 % | ||||
| Net Asset | 10.15 B |
About STERIS Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STERIS plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STERIS Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STERIS plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:Check out For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Health Care Equipment & Supplies sector continue expanding? Could STERIS diversify its offerings? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STERIS Plc data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.286 | Earnings Share 7.17 | Revenue Per Share | Quarterly Revenue Growth 0.099 | Return On Assets |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, STERIS Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.